This inventor holds 1 USPTO granted patent. Top assignee: Astrazeneca Ab. Active years: 2005.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2005
Title: Chris Allan Veale: Innovator in T Cell Mediated Condition Treatments
Introduction
Chris Allan Veale is a notable inventor based in Wilmington, DE (US). He has made significant contributions to the field of medical research, particularly in the development of treatments for T cell mediated conditions.
Latest Patents
Veale holds a patent for "Cd45 inhibitors - Substituted naphthalenediones in accord with structural diagram (I): compositions thereof and methods for the use thereof, for the treatment of T cell mediated conditions such as autoimmune diseases and organ graft rejection." This innovative patent addresses critical health issues by providing compositions that can potentially improve treatment outcomes for patients suffering from these conditions.
Career Highlights
Throughout his career, Chris Allan Veale has demonstrated a commitment to advancing medical science. His work has focused on creating effective solutions for complex health challenges, showcasing his expertise and dedication to innovation.
Collaborations
Veale has collaborated with esteemed colleagues, including Marc Chapdelaine and Katherine Knappenberger, to further enhance the impact of his research and inventions.
Conclusion
Chris Allan Veale's contributions to the field of medical research, particularly through his patent on Cd45 inhibitors, highlight his role as an innovator dedicated to improving treatments for T cell mediated conditions. His work continues to inspire advancements in medical science.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile